Estado vacunal de pacientes en tratamiento por VIH en un hospital de Madrid

IF 1.7 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Revista clinica espanola Pub Date : 2026-10-01 Epub Date: 2026-07-10 DOI:10.1016/j.rce.2026.502597

A. Alcaide-Jiménez, J.E. Losa, V. Hernández-Múgica, J.G. Sánchez, G. Rodríguez-Caravaca, P. Cárdenas-Soriano, A.M. Pedraza-Flechas

{"title":"Estado vacunal de pacientes en tratamiento por VIH en un hospital de Madrid","authors":"A. Alcaide-Jiménez, J.E. Losa, V. Hernández-Múgica, J.G. Sánchez, G. Rodríguez-Caravaca, P. Cárdenas-Soriano, A.M. Pedraza-Flechas","doi":"10.1016/j.rce.2026.502597","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>People living with HIV (PLHIV) are considered at high-risk for acquiring infections or experiencing severe disease. The Spanish Ministry of Health advises vaccination against pneumococcus, meningococcus, hepatitis A and B, tetanus, human papillomavirus (HPV), herpes zoster (HZ), varicella, and measles, mumps, and rubella (MMR) for PLHIV.</div><div>We aimed at determining the vaccination status of PLHIV on antiretroviral therapy (ART) in a hospital in Madrid in 2023.</div></div><div><h3>Methods</h3><div>Cross-sectional study in 96 PLHIV receiving ART. Vaccination status was evaluated regarding official recommendations. Coverage was calculated according to schedule.</div></div><div><h3>Results</h3><div>78.1% had received at least one dose of a vaccine as part of the recommended schedule. Completed schedule was more frequent for HZ (68.75%), followed by pneumococcus (38.54%) and meningococcus (2.01%). 12.50% had received at least on dose of the HPV vaccine and 20.83% had received a diphtheria/tetanus vaccine dose within the last 10 years. Immunity to hepatitis B and A was observed in 57.30% and 56.30%, respectively. Vaccination coverage during the 2022–2023 campaign was 50% for both, COVID-19 and influenza.</div></div><div><h3>Conclusions</h3><div>Patients’ compliance with vaccination schedules was acceptable in general, and low regarding meningococcal vaccination. Patient engagement and awareness strategies are essential to promote vaccination uptake in this population.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"226 8","pages":"Article 502597"},"PeriodicalIF":1.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014256526012063","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

People living with HIV (PLHIV) are considered at high-risk for acquiring infections or experiencing severe disease. The Spanish Ministry of Health advises vaccination against pneumococcus, meningococcus, hepatitis A and B, tetanus, human papillomavirus (HPV), herpes zoster (HZ), varicella, and measles, mumps, and rubella (MMR) for PLHIV.

We aimed at determining the vaccination status of PLHIV on antiretroviral therapy (ART) in a hospital in Madrid in 2023.

Methods

Cross-sectional study in 96 PLHIV receiving ART. Vaccination status was evaluated regarding official recommendations. Coverage was calculated according to schedule.

Results

78.1% had received at least one dose of a vaccine as part of the recommended schedule. Completed schedule was more frequent for HZ (68.75%), followed by pneumococcus (38.54%) and meningococcus (2.01%). 12.50% had received at least on dose of the HPV vaccine and 20.83% had received a diphtheria/tetanus vaccine dose within the last 10 years. Immunity to hepatitis B and A was observed in 57.30% and 56.30%, respectively. Vaccination coverage during the 2022–2023 campaign was 50% for both, COVID-19 and influenza.

Conclusions

Patients’ compliance with vaccination schedules was acceptable in general, and low regarding meningococcal vaccination. Patient engagement and awareness strategies are essential to promote vaccination uptake in this population.

查看原文本刊更多论文

马德里一家医院接受艾滋病毒治疗的患者的免疫状况

艾滋病毒感染者（PLHIV）被认为是获得感染或经历严重疾病的高危人群。西班牙卫生部建议对肺炎球菌、脑膜炎球菌、甲型和乙型肝炎、破伤风、人乳头瘤病毒（HPV）、带状疱疹（HZ）、水痘、麻疹、腮腺炎和风疹（MMR）进行预防接种。我们的目的是确定2023年马德里一家医院抗逆转录病毒治疗（ART）的PLHIV疫苗接种状况。方法对96例接受抗逆转录病毒治疗的hiv患者进行横断面研究。根据官方建议评估了疫苗接种状况。结果78.1%的儿童按照推荐接种计划接种了至少一剂疫苗。以HZ（68.75%）最高，其次为肺炎球菌（38.54%）和脑膜炎球菌（2.01%）。12.50%的人至少接种过一次人乳头瘤病毒疫苗，20.83%的人在过去10年内接种过一次白喉/破伤风疫苗。对乙型肝炎和甲型肝炎的免疫力分别为57.30%和56.30%。2022-2023年运动期间，COVID-19和流感的疫苗接种覆盖率均为50%。结论患者对疫苗接种计划的依从性总体上可以接受，但对脑膜炎球菌疫苗接种的依从性较低。患者参与和意识策略对于促进这一人群的疫苗接种至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista clinica espanola 医学-医学：内科

CiteScore

4.40

自引率

6.90%

发文量

审稿时长

28 days

期刊介绍： Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI). The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Nine issues are published each year, including mostly originals, reviews and consensus documents.